![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fbanner-two-shape-left.6c4ab631.png&w=3840&q=75)
![Hero Image](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fhero-right-top.b8bd1734.webp&w=3840&q=75)
Last updated at 23 hours ago
Director
DIN: 10357406
Sangita Malpani is currently associated with 2 companies in various capacities such as Designated Partner and Individual Subscriber. They serve as a Director at ABHIRAJ SOLUTIONS AND REMEDIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10357406.Sangita Malpani is currently involved in 2 different roles. Their most recent position is with DHANADA PROJECTS PRIVATE LIMITED as a Individual Subscriber. The first company Sangita Malpani was appointed to was ABHIRAJ SOLUTIONS AND REMEDIES LLP. Sangita Malpani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sangita Malpani is currently associated with 2 companies in various capacities such as Designated Partner and Individual Subscriber. They serve as a Director at ABHIRAJ SOLUTIONS AND REMEDIES LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10357406.Sangita Malpani is currently involved in 2 different roles. Their most recent position is with DHANADA PROJECTS PRIVATE LIMITED as a Individual Subscriber. The first company Sangita Malpani was appointed to was ABHIRAJ SOLUTIONS AND REMEDIES LLP. Sangita Malpani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (0)
2 Months 1 Month Interval
Company Name | Designation | Date of Appointment |
---|---|---|
DHANADA PROJECTS PRIVATE LIMITED | Individual Subscriber | 30-Nov-2024 |